
A High Court battle between rival developers of Covid-19 jabs over patents for vaccine technology is set to be heard in London next year.
Pharmaceutical giant Pfizer and drug manufacturer BioNTech are locked in a dispute with vaccine maker Moderna over the use of messenger RNA (mRNA) technology in coronavirus jabs, with similar litigation taking place in the US, Germany and the Netherlands.